CASE (CemiplimAb-rwlc Survivorship and Epidemiology): a study in advanced basal cell carcinoma.
Park SJ, Ellison DM, Weight R, Homsi J, Rabinowits G, Ruiz ES, Strasswimmer J, Simmons J, Panella T, Quek RG, Pouliot JF, Khushalani NI.
Park SJ, et al. Among authors: ruiz es.
Future Oncol. 2025 Jan 11:1-6. doi: 10.1080/14796694.2024.2448416. Online ahead of print.
Future Oncol. 2025.
PMID: 39797702